Hamilton Wealth LLC Boosts Bristol Myers Squibb Stake

Investment firm increases holding in biopharmaceutical company by over 150%

Mar. 16, 2026 at 11:21am

Got story updates? Submit your updates here. ›

Hamilton Wealth LLC has significantly increased its stake in Bristol Myers Squibb Company, a major biopharmaceutical firm. According to a recent SEC filing, the investment firm boosted its position in Bristol Myers Squibb by 156.7% in the third quarter, now owning 199,783 shares worth $9.01 million.

Why it matters

This move by Hamilton Wealth LLC suggests the investment firm sees strong potential in Bristol Myers Squibb, a leading pharmaceutical company focused on developing innovative cancer and immune-mediated disease treatments. The increased stake reflects Hamilton Wealth's confidence in Bristol Myers Squibb's future growth prospects.

The details

Hamilton Wealth LLC purchased an additional 121,956 shares of Bristol Myers Squibb in the third quarter, bringing its total holding to 199,783 shares. This represents about 1.9% of the firm's total portfolio. Bristol Myers Squibb is now the 16th largest position held by Hamilton Wealth.

  • Hamilton Wealth LLC filed its latest 13F report with the SEC in the third quarter of 2026.

The players

Hamilton Wealth LLC

An investment management firm that oversees a portfolio of stocks, bonds, and other assets for its clients.

Bristol Myers Squibb Company

A major biopharmaceutical company focused on developing innovative cancer and immune-mediated disease treatments.

Got photos? Submit your photos here. ›

The takeaway

Hamilton Wealth's significant increase in its Bristol Myers Squibb stake suggests the investment firm sees strong growth potential in the biopharmaceutical company's pipeline and future prospects. This move highlights the confidence some institutional investors have in Bristol Myers Squibb's ability to deliver value for shareholders.